Effects of (DesGly9-Arg8) vasopressin on cognitive processes in alcoholic patients. 1991

M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
University Department of Medicine, Medical Faculty, University of Zagreb.

The effect of intranasally administered (DesGly9-Arg8) vasopressin (DGAVP) on certain aspects of cognitive functions of alcoholic patients was studied. The investigation was carried out in 103 chronic alcoholic patients. None of the patients suffered from Korsakoff's syndrome, portal encephalopathy or brain damage of other etiology. The trial was double-blind, placebo controlled. Psychological testing, which included certain aspects of attention, short-term and long-term memory and spatial orientation, was carried out on the day before (baseline measurements), on the last day (II), and seven days after the last administration of DGAVP (III). No treatment effect of DGAVP was observed. The results show that investigations with humans are infinitely more complex than those with animals, since a number of physiological and socio-psychological factors must be controlled. In this study of alcoholics two such factors: 1) duration of abstinence and 2) adaptation to test situation were identified.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D013695 Temperance Habitual moderation in the indulgence of a natural appetite, especially but not exclusively the consumption of alcohol. Temperances

Related Publications

M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
July 1987, Acta endocrinologica,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
January 1992, Peptides,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
February 1999, Japanese journal of pharmacology,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
October 1994, Neuroscience,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
September 1980, Biochemical and biophysical research communications,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
April 2003, Methods and findings in experimental and clinical pharmacology,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
October 1996, European journal of pharmacology,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
January 1990, Neuropsychobiology,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
January 1988, Life sciences,
M Korsić, and N Jokić, and D Ilić-Supek, and Z Skocilić, and M Lovrić, and J Bacić, and M Jakovljević, and K Maslo, and M Trbović
January 1996, American journal of obstetrics and gynecology,
Copied contents to your clipboard!